InvestorsHub Logo
Post# of 251306
Next 10
Followers 828
Posts 119330
Boards Moderated 16
Alias Born 09/05/2002

Re: oc631 post# 160554

Tuesday, 04/30/2013 6:04:02 PM

Tuesday, April 30, 2013 6:04:02 PM

Post# of 251306
VRTX’s NCT01726946 trial is billed as a safety and efficacy study and is measuring SVR, but they aren’t fooling anyone, evidently.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.